摘要
目的:探讨吸入用布地奈德混悬液雾化吸入治疗小儿毛细支气管炎的疗效。方法:将102例毛细支气管炎患儿以随机数字表法分为观察组和对照组各51例,2组均给予静脉滴注喜炎平注射液、利巴韦林注射液、二羟丙茶碱注射液等综合治疗,观察组患儿加用吸入用布地奈德混悬液雾化吸入。对比观察2组患儿治疗前后症状、体征消失或缓解时间。结果:观察组患儿的咳嗽消失、哮鸣音消失、湿罗音消失时间均明显短于对照组,差异有统计学意义(P<0.05);观察组患儿的痊愈率为74.51%(38/51),明显高于对照组的52.94%(27/51),差异有统计学意义(P<0.05)。结论:吸入用布地奈德混悬液雾化吸入治疗小儿毛细支气管炎,疗效确切,方便、安全,可缩短病程。
OBJECTIVE：To investigate the efficacy of budesonide inhalation suspension for capillary bronchitis in children. METHODS：102 children with capillary bronchitis were randomly divided into treatment group and control group of 51 cases each. The control group received conventional therapy alone,including Xiyanping injection,ribavirin injection and diprophylline injection iv. gtt,while the treatment group received add-on budesonide inhalation suspension plus the conventional therapy. The symptoms before and after treatment and the duration of symptoms were recorded and compared between the two groups. RESULTS：The time of cough disappeard, wheeze disappeared, moist rales disappeared in the treatment group were significantly shorter than the control group（P〈0. 05）;the recovery rate of the treatment group was significantly higher than the control group[74. 51%（38/51）vs. 52. 94%（27/51）,P〈0. 05]. CONCLUSIONS：Budesonide inhalation suspension is safe, effectiv and convenient to use in treatment of capillary bronchitis in children and it can shorten the course of treatment.
出处
《中国医院用药评价与分析》
2015年第8期1023-1024,共2页
Evaluation and Analysis of Drug-use in Hospitals of China
